For instance, in some overgrowth syndromes such as PIK3CA-related overgrowth spectrum (PROs), even advanced genetic testing such as next-generation sequencing may be negative when performed from blood samples, and not from the affected tissue [18]. The gene discussed is PIK3CA; the disease is overgrowth syndrome.